Treatment Efficacy and Molecular Dynamics of Neoadjuvant Durvalumab and Olaparib in Resectable Urothelial Bladder Cancer: The NEODURVARIB Trial

  1. Rodríguez-Moreno,J.F.
  2. de Velasco,G.
  3. Álvarez-Fernández,C.
  4. Collado,R.
  5. Fernández,R.
  6. Vázquez,S.
  7. Virizuela,J.A.
  8. Gajate,P.
  9. Font,A.
  10. Lainez,N.
  11. Sevillano-Fernández,E.
  12. Graña-Castro,O.
  13. Beltrán,L.
  14. Madurga,R.
  15. Rodríguez-Antona,C.
  16. Berraondo,P.
  17. Ruiz-Llorente,S.
  18. García-Donas,J.
Journal:
Clinical cancer research : an official journal of the American Association for Cancer Research

ISSN: 1557-3265

Year of publication: 2025

Volume: 31

Issue: 9

Pages: 1644-1656

Type: Article

DOI: 10.1158/1078-0432.CCR-24-2890 GOOGLE SCHOLAR lock_openOpen access editor
Data source: Scopus